Skip to main content
Premium Trial:

Request an Annual Quote

ARUP Joins PierianDx Partner Network

NEW YORK (GenomeWeb) – ARUP Laboratories has joined PierianDx's partner network, the firms said today. ARUP will use PierianDx's workflow management tools and next-generation sequencing knowledgebase for its NGS-based clinical tests.

PierianDx was spun off earlier this year from Washington University in St. Louis. Its first product was the Clinical Genomicist Workstation, software developed by Wash U researchers, and the company also provides a knowledgebase of clinical information from thousands of previous genomic tests that its customers can tap into.

ARUP President and CEO Edward Ashwood said in a statement that PierianDx’s software and database will enable the lab to "more effectively learn from past assays and provide even more personalized recommendations to physicians so they can better match their patients to the right therapies."

In addition, PierianDx will benefit from "insight provided by ARUP clinical interpretations, variants, and related de-identified patient information," PierianDx CEO Ted Briscoe said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.